Alexandra Ainatzoglou

Aristotle University of Thessaloniki - Department of Clinical Pharmacology

Greece

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 37,241

SSRN RANKINGS

Top 37,241

in Total Papers Downloads

1,958

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Immunogenicity after the First Dose of the BNT162b2 mRNA COVID-19 Vaccine: Real-World Evidence from Greek Healthcare Workers

Number of pages: 10 Posted: 19 Feb 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 1,249 (24,412)
Citation 2

Abstract:

Loading...

vaccine, BNT162b2, SARS-CoV-2, immunogenicity, healthcare workers, Greece, reactogenicity

2.

Second Dose of the BNT162b2 mRNA Vaccine in Greece: The Value of Timely Administration

Number of pages: 8 Posted: 01 Apr 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 296 (150,907)

Abstract:

Loading...

BNT162b2 mRNA vaccine, immunogenicity, seropositive, Greece

3.

Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Elderly People Over 85 Years of Age in Greece

Number of pages: 10 Posted: 11 Jun 2021
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 236 (189,149)
Citation 1

Abstract:

Loading...

BNT162b2 mRNA COVID-19 vaccine, immunogenicity, SARS-CoV-2, elderly over age 85, Greece

4.

Evolution of Antibody Titers Up to 6 Months Post-Immunization With the BNT162b2 Pfizer/BioNTech Vaccine in Greece

Number of pages: 12 Posted: 15 Sep 2021
G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 177 (245,523)

Abstract:

Loading...

BNT162b2 mRNA Covid-19 vaccine; immunogenicity; antibodies; SARS-CoV-2; 6-months post-vaccination; healthcare workers, Greece